Factor This Power Engineering
Live Events
DTECH® Events
POWERGENâ¢
Calendar
Webinars
Podcasts
Contribute Content
Solar
Community
Residential
Utility Scale
Wind Power
Offshore
Turbines & Equipment
Power Grid
Distribution
Grid Modernization
Microgrids
Outage Management
Smart Grids
Transmission
Hydropower
Dams & Civil Structures
Small Hydropower
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Long Duration
Pumped Storage
Business
Finance
Policy & Regulation
Project Development
Tariffs
Electric Vehicles
EV Charging
Vehicle to Grid
Subscribe
Solar
Community
Residential
Utility Scale
Wind Power
Offshore
Turbines & Equipment
Power Grid
Distribution
Grid Modernization
Microgrids
Outage Management
Transmission
Smart Grids
Hydropower
Dams & Civil Structures
Small Hydro
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Long Duration
Pumped Storage
Business
Finance
Policy & Regulation
Electric Vehicles
EV Charging
Vehicle to Grid
Factor This: Power Engineering
Live Events
DISTRIBUTECH®
Podcasts
Webinars
Calendar
Contribute Content
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
EL&P Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Oncotelic Therapeutics, Inc.
Sapu Nano’s Sapu003 Advances to Human Clinical Testing - Transforming Everolimus Delivery with Full Bioavailability for Breast Cancer Patients
September 24, 2025
From
Oncotelic Therapeutics, Inc.
Via
GlobeNewswire
Tickers
OTLC
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Creating Pioneering Pipeline Designed to Transform Cancer, Rare Diseases Treatments
September 18, 2025
From
Oncotelic Therapeutics, Inc.
Via
GlobeNewswire
Tickers
OTLC
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Building Breakthrough Portfolio Aimed at Transforming Cancer, Rare Disease Treatments
September 16, 2025
From
Oncotelic Therapeutics, Inc.
Via
GlobeNewswire
Tickers
OTLC
Oncotelic Therapeutics Highlights 2 Years of Clinical and Regulatory Advancements Across Late-Stage Pipeline
September 12, 2025
From
Oncotelic Therapeutics, Inc.
Via
GlobeNewswire
Tickers
OTLC
Dr. Vuong Trieu, Developer of Novel Oncology and Immunotherapy Assets, Leads Oncotelic Therapeutics’ Commitment to Innovation, Life-Saving Therapies
September 04, 2025
From
Oncotelic Therapeutics, Inc.
Via
GlobeNewswire
Tickers
OTLC
Oncotelic Publishes SNO 27th Annual Meeting Presentation Materials
November 30, 2022
From
Oncotelic Therapeutics, Inc.
Via
GlobeNewswire
Tickers
OTLC
Oncotelic Reports Q3 2022 Compared to Q3 2021 Financial Results
November 21, 2022
From
Oncotelic Therapeutics, Inc.
Via
GlobeNewswire
Tickers
OTLC
Oncotelic Publishes SITC Meeting 2022 Presentation Materials
November 16, 2022
From
Oncotelic Therapeutics, Inc.
Via
GlobeNewswire
Tickers
OTLC
Oncotelic Initiates Clinical Trials Evaluating OT-101 against Pediatric Gliomas
November 08, 2022
From
Oncotelic Therapeutics, Inc.
Via
GlobeNewswire
Tickers
OTLC
Oncotelic Awarded BARDA Funding for Development of OT-101 for long COVID
October 12, 2022
From
Oncotelic Therapeutics, Inc.
Via
GlobeNewswire
Tickers
OTLC
Oncotelic Announces Formation of Animal Health Division
October 06, 2022
From
Oncotelic Therapeutics, Inc.
Via
GlobeNewswire
Tickers
OTLC
Oncotelic Presenting Data for OT101 Against Pancreatic Cancer (PDAC) at the SITC 37th Annual Meeting
September 28, 2022
From
Oncotelic Therapeutics, Inc.
Via
GlobeNewswire
Tickers
OTLC
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.